Gilteritinib
Back to searchMolecule Structure
Scientific Name
Gilteritinib
Description of the Drug
Gilteritinib is an AXL receptor tyrosine kinase inhibitor used to treat relapsed or refractory acute myeloid leukemia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12141
http://www.drugbank.ca/drugs/DB12141
Brand Name(s)
Not Available
Company Owner(s)
Astellas Pharma Us Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Tyrosine-protein kinase receptor UFO | SINGLE PROTEIN | INHIBITOR | CHEMBL4895 |
| Tyrosine-protein kinase receptor FLT3 | SINGLE PROTEIN | INHIBITOR | CHEMBL1974 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL282229 | ||
| Human Metabolome Database | HMDB0252717 | ||
| DrugBank | DB12141 | ||
| PubChem: Thomson Pharma | 103775109 | ||
| PubChem | 49803313 | ||
| Nikkaji | J3.425.284J | ||
| PDBe | C6F | ||
| BindingDB | 144315 | ||
| DrugCentral | 5306 | ||
| ChemicalBook | CB82725626 | ||
| Guide to Pharmacology | 8708 | ||
| rxnorm | XOSPATA | GILTERITINIB FUMARATE | GILTERITINIB |
| ChEBI | 145372 | ||
| ZINC | ZINC000113476229 |
